Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF79 Inhibitors

ZNF79 inhibitors represent a class of compounds that interact with zinc finger protein 79 (ZNF79), a member of the C2H2-type zinc finger protein family. These proteins are characterized by the presence of zinc finger motifs, which are small, functional domains capable of binding to zinc ions, facilitating their interactions with DNA, RNA, or other proteins. ZNF79, like other zinc finger proteins, plays a key role in regulating gene expression through its ability to bind to specific DNA sequences. By modulating the activity of ZNF79, inhibitors can alter the transcriptional activity of genes under its control. This can impact cellular processes such as differentiation, proliferation, and signal transduction. ZNF79 inhibitors, therefore, affect the structural conformation or the DNA-binding ability of this protein, thereby disrupting the precise regulation of target genes involved in various cellular pathways.

The design of ZNF79 inhibitors is based on the understanding of the molecular structure of ZNF79, including its zinc-binding motifs and DNA-interaction regions. Researchers typically utilize high-throughput screening methods to identify small molecules that can bind specifically to the active site of ZNF79 or its allosteric sites, which can change its functional state. Advanced computational modeling and structural biology tools such as X-ray crystallography or NMR spectroscopy are often employed to investigate the inhibitor's binding characteristics and optimize their selectivity. Additionally, modifications to the chemical structure of these inhibitors are explored to enhance their binding affinity and stability within biological systems. This detailed understanding of ZNF79's structure and function allows for the development of inhibitors that can precisely modulate its role in gene expression, providing a valuable tool for studying the intricate mechanisms of transcriptional regulation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can affect protein synthesis, potentially altering the function of ZNF79.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can disrupt signaling, potentially influencing ZNF79's regulatory roles.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can affect the MAPK/ERK pathway, potentially modulating ZNF79 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that can alter stress response, potentially affecting ZNF79 function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can change stress response and apoptosis, potentially influencing ZNF79.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that can disrupt MAPK/ERK signaling, potentially affecting ZNF79's activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that can lead to protein accumulation, potentially impacting ZNF79 levels.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can stabilize proteins, potentially affecting ZNF79's degradation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor that can change gene expression, potentially influencing ZNF79 activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC inhibitor that can alter chromatin structure, potentially modulating ZNF79 expression.